COVID-19 is still a relatively new disease with its long-term impact still not fully understood. Extrapolation from UK data suggests that up to 15-20% COVID-19 patients could present long-term symptoms with evidence of this already presenting. The AFTERCOR study aims to elucidate the long-term effects of COVID-19. In particular, the AFTERCOR study will characterise renal, pulmonary, hepatic and neurological dysfunctions post COVID-19 and resulting health-related quality of life. The results of the study will assist clinicians treating COVID-19 long haulers, providing valuable insights on the longer term impacts and pave the way for interventions aimed at improving health outcomes and quality of life.